Lesley Russell
Director/Board Member at CHIMERIC THERAPEUTICS LIMITED
Net worth: 1 M $ as of 2024-04-29
Profile
Lesley Russell is currently serving as a Non-Executive Director at Imugene Ltd., Enanta Pharmaceuticals, Inc., Melmark, Inc., and Chimeric Therapeutics Ltd.
She is also a Member of The Royal College of Physicians.
Previously, she served as an Independent Director at Endocyte, Inc. and AMAG Pharmaceuticals, Inc. She was also the Chief Medical Officer & Executive Vice President at Cephalon, Inc. and Vice President-Clinical Research at MedImmune LLC and U.S.
Bioscience, Inc. She has also held positions at TetraLogic Pharmaceuticals Corp., Teva Pharmaceuticals USA, Inc., and Innocoll Holdings Plc.
She received her undergraduate degree from The University of Edinburgh in 1985.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
IMUGENE LTD
0.28% | 2024-01-11 | 20,238,095 ( 0.28% ) | 1 M $ | 2024-04-29 |
2024-03-05 | 0 ( -.--% ) | - $ | 2024-04-29 |
Lesley Russell active positions
Companies | Position | Start |
---|---|---|
ENANTA PHARMACEUTICALS, INC. | Director/Board Member | 2016-11-17 |
IMUGENE LIMITED | Director/Board Member | 2019-04-22 |
CHIMERIC THERAPEUTICS LIMITED | Director/Board Member | 2020-08-27 |
Melmark, Inc.
Melmark, Inc. Other Consumer ServicesConsumer Services Melmark, Inc. engages in the provision of residential, educational, therapeutic, and recreational services for children and adults with developmental disabilities. It offers programs and services for children and young adult, and adults. The company was founded by Paul Krentel and Mildred Krentel in 1966 and is headquartered in Berwyn, PA. | Director/Board Member | 2012-12-31 |
The Royal College of Physicians | Corporate Officer/Principal | 1986-12-31 |
Former positions of Lesley Russell
Companies | Position | End |
---|---|---|
SCOPUS BIOPHARMA INC. | Director/Board Member | 2021-02-28 |
AMAG PHARMACEUTICALS, INC. | Director/Board Member | 2019-05-15 |
ENDOCYTE, INC. | Director/Board Member | 2018-12-20 |
Endocyte Pharmaceuticals, Inc. | Director/Board Member | 2018-11-30 |
░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Training of Lesley Russell
The University of Edinburgh | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
ENANTA PHARMACEUTICALS, INC. | Health Technology |
IMUGENE LIMITED | Health Technology |
CHIMERIC THERAPEUTICS LIMITED | Health Technology |
SCOPUS BIOPHARMA INC. | Health Technology |
Private companies | 12 |
---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
U.S. Bioscience, Inc.
U.S. Bioscience, Inc. BiotechnologyHealth Technology U.S. Bioscience, Inc. is a pharmaceutical company specializing in the development and commercialization of products for patients with cancer and AIDS and allied infections. The company has three products on the market. In addition to its headquarters, U.S. Bioscience has a manufacturing facility located in Nijmegen, The Netherlands, an analytical laboratory in Exton, PA, and a subsidiary near London to coordinate clinical trials in Europe. U.S. Bioscience, Inc. is headquartered in West Conshohocken, PA. | Health Technology |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Health Technology |
USB Pharma Ltd. | |
Amgen Ltd.
Amgen Ltd. Miscellaneous Commercial ServicesCommercial Services Amgen Ltd. operates as a biotechnology firm. It engages in the research and development of human therapeutics to treat illnesses. The company was founded on March 1, 1989 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
Endocyte, Inc.
Endocyte, Inc. Pharmaceuticals: MajorHealth Technology Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN. | Health Technology |
Innocoll Holdings Plc
Innocoll Holdings Plc Pharmaceuticals: MajorHealth Technology Innocoll Holdings Plc operates as a pharmaceutical company. It focuses on the development and commercialization of pharmaceutical technologies to meet healthcare challenges. The firm's late-stage product pipeline is focused on addressing patient needs for postsurgical pain management. The company was founded in 1997 and is headquartered in Athlone, Ireland. | Health Technology |
Melmark, Inc.
Melmark, Inc. Other Consumer ServicesConsumer Services Melmark, Inc. engages in the provision of residential, educational, therapeutic, and recreational services for children and adults with developmental disabilities. It offers programs and services for children and young adult, and adults. The company was founded by Paul Krentel and Mildred Krentel in 1966 and is headquartered in Berwyn, PA. | Consumer Services |
Endocyte Pharmaceuticals, Inc. | |
Sojournix, Inc.
Sojournix, Inc. BiotechnologyHealth Technology Sojournix, Inc. operates in the healthcare industry focusing on biotechnology business. It develops medicines for women’s health and endocrine disorders. The company was founded by Scott L. Rakestraw and Daniel Grau in 2016 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Lesley Russell